These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 986052)

  • 21. Mode of antagonistic action of levallorphan in morphine-dependent rats and assessment of physical dependence liability.
    Tagashira E; Izumi T; Yanaura S
    Jpn J Pharmacol; 1979 Aug; 29(4):623-30. PubMed ID: 575396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxytocin mediates the inhibitory action of acute lithium on the morphine dependence in rats.
    You ZD; Li JH; Song CY; Lu CL; He C
    Neurosci Res; 2001 Oct; 41(2):143-50. PubMed ID: 11591442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of withdrawal in reinstatement of morphine-conditioned place preference.
    Lu L; Chen H; Su W; Ge X; Yue W; Su F; Ma L
    Psychopharmacology (Berl); 2005 Aug; 181(1):90-100. PubMed ID: 15739075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mu- and delta-opioid receptor antagonists precipitate similar withdrawal phenomena in butorphanol and morphine dependence.
    Feng YZ; Zhang T; Tokuyama S; Zhu H; Rockhold RW; Ho IK
    Neurochem Res; 1996 Jan; 21(1):63-71. PubMed ID: 8833225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Height-dependent difference in the expression of naloxone-induced withdrawal jumping behavior in morphine dependent rats.
    Azizi H; Ranjbar-Slamloo Y; Semnanian S
    Neurosci Lett; 2012 May; 515(2):174-6. PubMed ID: 22465245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of different brain structures in the expression of the physical morphine withdrawal syndrome.
    Maldonado R; Stinus L; Gold LH; Koob GF
    J Pharmacol Exp Ther; 1992 May; 261(2):669-77. PubMed ID: 1578378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for a role of nitric oxide of the central nervous system in morphine abstinence syndrome.
    Bhargava HN; Thorat SN
    Pharmacology; 1996 Feb; 52(2):86-91. PubMed ID: 8851629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ionotropic glutamatergic neurotransmission in the ventral tegmental area modulates DeltaFosB expression in the nucleus accumbens and abstinence syndrome in morphine withdrawal rats.
    Wang HL; Xiang XH; Guo Y; Wu WR; Cao DY; Wang HS; Zhao Y
    Eur J Pharmacol; 2005 Dec; 527(1-3):94-104. PubMed ID: 16303124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic morphine-induced release of serotonin in the rostroventral medulla is not mimicked by morphine microinjection into the periaqueductal gray.
    Taylor BK; Basbaum AI
    J Neurochem; 2003 Sep; 86(5):1129-41. PubMed ID: 12911621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid induction and quantitation of morphine dependence in the rat by pellet implantation.
    Bhargava HN
    Psychopharmacology (Berl); 1977 Mar; 52(1):55-62. PubMed ID: 403558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Constitutive mu opioid receptor activation as a regulatory mechanism underlying narcotic tolerance and dependence.
    Wang Z; Bilsky EJ; Porreca F; Sadée W
    Life Sci; 1994; 54(20):PL339-50. PubMed ID: 7514710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitory effect of neuropeptide Y on morphine withdrawal is accompanied by reduced c-fos expression in specific brain regions.
    Clausen TR; Møller M; Woldbye DP
    J Neurosci Res; 2001 May; 64(4):410-7. PubMed ID: 11340648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analog of neuropeptide FF attenuates morphine abstinence syndrome.
    Malin DH; Lake JR; Leyva JE; Hammond MV; Rogillio RB; Arcangeli KR; Ludgate K; Moore GM; Payza K
    Peptides; 1991; 12(5):1011-4. PubMed ID: 1800944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence of a preferential role of brain serotonin in the mechanisms leading to naloxone-precipitated compulsive jumping in morphine-dependent rats.
    Cervo L; Rochat C; Romandini S; Samanin R
    Psychopharmacology (Berl); 1981; 74(3):271-4. PubMed ID: 6791237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of ATP-dependent K+ channels on nicotine-induced inhibition of withdrawal in morphine-dependent mice.
    Zarrindast MR; Mohajeri S
    Eur J Pharmacol; 2006 Dec; 552(1-3):90-8. PubMed ID: 17049514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of corticotropin-releasing hormone in the amygdala and bed nucleus of the stria terminalis in the behavioral, pain modulatory, and endocrine consequences of opiate withdrawal.
    McNally GP; Akil H
    Neuroscience; 2002; 112(3):605-17. PubMed ID: 12074902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The bed nucleus of the stria terminalis. A target site for noradrenergic actions in opiate withdrawal.
    Aston-Jones G; Delfs JM; Druhan J; Zhu Y
    Ann N Y Acad Sci; 1999 Jun; 877():486-98. PubMed ID: 10415666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of precipitated withdrawal symptoms by activating central cholinergic systems during a dependence-producing schedule of morphine in rats.
    Buccafusco JJ; Zhang LC; Shuster LC; Jonnala RR; Gattu M
    Brain Res; 2000 Jan; 852(1):76-83. PubMed ID: 10661498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac adverse effects of naloxone-precipitated morphine withdrawal on right ventricle: role of corticotropin-releasing factor (CRF) 1 receptor.
    Navarro-Zaragoza J; Martínez-Laorden E; Mora L; Hidalgo J; Milanés MV; Laorden ML
    Toxicol Appl Pharmacol; 2014 Feb; 275(1):28-35. PubMed ID: 24398105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Presynaptic dopaminergic function in the nucleus accumbens following chronic opiate treatment and precipitated withdrawal.
    Ghosh S; Grasing K
    Neurochem Res; 1999 Jan; 24(1):95-107. PubMed ID: 9973242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.